7,962 Stryker Corporation $SYK Shares Bought by Compass Capital Management Inc.

Compass Capital Management Inc. grew its holdings in shares of Stryker Corporation (NYSE:SYK) by 5.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 168,441 shares of the medical technology company’s stock after purchasing an additional 7,962 shares during the period. Stryker makes up 2.9% of Compass Capital Management Inc.’s portfolio, making the stock its 20th biggest holding. Compass Capital Management Inc.’s holdings in Stryker were worth $46,387,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the business. Bank of America Corp DE acquired a new position in Stryker in the second quarter worth approximately $1,404,284,000. Legal & General Group Plc acquired a new stake in shares of Stryker during the 2nd quarter valued at $707,212,000. Jupiter Topco LLC acquired a new stake in shares of Stryker during the 2nd quarter valued at $681,581,000. Corient Private Wealth LP bought a new stake in shares of Stryker during the 2nd quarter worth $323,035,000. Finally, Flossbach Von Storch SE bought a new stake in shares of Stryker during the 2nd quarter worth $464,506,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SYK. Canaccord Genuity Group lowered Stryker from a “buy” rating to a “hold” rating and cut their target price for the stock from $385.00 to $300.00 in a research report on Friday, October 30th. Truist Financial reiterated a “hold” rating and issued a $305.00 price target (down from $310.00) on shares of Stryker in a research report on Monday, November 2nd. Evercore lifted their price target on Stryker from $335.00 to $355.00 in a research note on Wednesday, October 28th. Deutsche Bank cut their price objective on Stryker from $315.00 to $275.00 and set a “hold” rating on the stock in a report on Friday, October 30th. Finally, TD Cowen reduced their price objective on shares of Stryker from $298.00 to $290.00 and set a “hold” rating for the company in a research note on Friday, October 30th. Twenty-one research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $342.19.

Stryker Stock Down 1.1%

Stryker stock opened at $309.05 on Friday. Stryker Corporation has a twelve month low of $267.00 and a twelve month high of $389.33. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. The firm has a market cap of $117.65 billion, a PE ratio of 32.91, a P/E/G ratio of 2.14 and a beta of 0.78. The firm’s 50 day moving average price is $292.30 and its two-hundred day moving average price is $322.60.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). Stryker had a net margin of 13.78% and a return on equity of 23.74%. The company had revenue of $6.52 billion for the quarter, compared to analyst estimates of $6.62 billion. During the same period last year, the business earned $3.19 EPS. The company’s quarterly revenue was up 7.6% on a year-over-year basis. On average, research analysts predict that Stryker Corporation will post 14.85 EPS for the current fiscal year.

Insider Buying and Selling at Stryker

In other Stryker news, insider Dylan Crotty sold 441 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $328.61, for a total value of $144,917.01. Following the transaction, the insider directly owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This represents a 6.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Debra King sold 826 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the sale, the insider directly owned 6,210 shares of the company’s stock, valued at $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 901,267 shares of company stock worth $297,123,701 over the last 90 days. 4.60% of the stock is currently owned by corporate insiders.

About Stryker

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.